prednisolone acetate has been researched along with Multiple Sclerosis, Relapsing-Remitting in 2 studies
prednisolone acetate: RN given refers to cpd with locant for acetate group in position 21 & (11 beta)-isomer
Multiple Sclerosis, Relapsing-Remitting: The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jasani, KM | 1 |
| Sharaf, N | 1 |
| Rog, D | 1 |
| Aslam, T | 1 |
| Gaskin, JC | 1 |
| Coote, M | 1 |
2 other studies available for prednisolone acetate and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
Fingolimod-associated macular oedema.
Topics: Anti-Inflammatory Agents; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macula | 2017 |
Postoperative cystoid macular oedema in a patient on fingolimod.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Diclofenac; Female; Fingolimod Hydroch | 2015 |